Publicacións en colaboración con investigadores/as de Hospital Universitario Araba (22)

2024

  1. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

2022

  1. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

    Reumatologia Clinica, Vol. 18, Núm. 1, pp. 33-41

2021

  1. Delayed Neurological Improvement After Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke

    Stroke, Vol. 52, Núm. 7, pp. 2210-2217

  2. Genomic Analysis of Ciprofloxacin-Resistant Salmonella enterica Serovar Kentucky ST198 From Spanish Hospitals

    Frontiers in Microbiology, Vol. 12

  3. Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimeŕs disease

    Neural Regeneration Research

  4. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

2020

  1. Clinical characteristics and outcomes of venous thromboembolic events after hallux valgus surgery: insights from the RIETE registry

    Journal of Thrombosis and Thrombolysis, Vol. 49, Núm. 4, pp. 651-658

  2. Heparan sulfate proteoglycans undergo differential expression alterations in alzheimer disease brains

    Journal of Neuropathology and Experimental Neurology, Vol. 79, Núm. 5, pp. 474-483

  3. Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain

    European Journal of Neurology, Vol. 27, Núm. 12, pp. 2491-2498

  4. Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: a Preliminary Study with Clinical Relevance

    Pathology and Oncology Research, Vol. 26, Núm. 1, pp. 167-173

  5. Prospective multicentre study of rectal carriage of multidrug-resistant Enterobacteriaceae among health-care workers in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 5, pp. 649.e1-649.e4

  6. The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Brains with sporadic Creutzfeldt-Jakob disease and copathology showed a prolonged end-stage of disease

    Journal of Clinical Pathology, Vol. 71, Núm. 5, pp. 446-450

  2. Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report

    Cellular Oncology, Vol. 41, Núm. 2, pp. 213-221

2017

  1. Heparan sulfate proteoglycans and heparanases in Alzheimer’s disease: Current outlook and potential therapeutic targets

    Neural Regeneration Research

  2. Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 58, Núm. 1, pp. 185-192

2016

  1. Heparanase and heparanase 2 display differently deregulation in neuroendocrine tumors, depending on their differentiation grade

    Histology and Histopathology, Vol. 31, Núm. 1, pp. 73-81

2015

  1. Bruton’s tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma

    Virchows Archiv, Vol. 466, Núm. 2, pp. 229-235

  2. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character

    BMC Cancer, Vol. 15, Núm. 1, pp. 1

2011

  1. Revisiting genome wide association studies (GWAS) in coeliac disease: Replication study in Spanish population and expression analysis of candidate genes

    Journal of Medical Genetics, Vol. 48, Núm. 7, pp. 493-496